Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Comi

Showing results (541-550 of 586) with videos related to

Pageof 59
Sort By:
Human Mutation|February 5, 1998
Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermiaB M Manning, K A Quane, P J Lynch, et al.
Heart (British Cardiac Society)|March 5, 1999
Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failureE Arbustini, R Fasani, P Morbini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 15, 2018
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimodL Ferre', F Clarelli, G Sferruzza, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 3, 2007
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term resultsA Ghezzi, M P Amato, M Capobianco, et al.
Diabetes, Obesity & Metabolism|May 5, 2012
Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trialL D Monti, E Setola, P C G Lucotti, et al.
Human Gene Therapy|June 2, 2001
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitisP L Poliani, H Brok, R Furlan, et al.
European Journal of Neurology|March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosisA Novotna, J Mares, S Ratcliffe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS studyM S Freedman, G S Francis, E A C M Sanders, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2008
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosisM Gironi, F Martinelli-Boneschi, P Sacerdote, et al.
Brain Stimulation|December 5, 2013
Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot studyF Spagnolo, M A Volonté, M Fichera, et al.
Pageof 59

Showing results (541-550 of 586) with videos related to

Sort By:
Pageof 59
Human Mutation|February 5, 1998
Novel mutations at a CpG dinucleotide in the ryanodine receptor in malignant hyperthermiaB M Manning, K A Quane, P J Lynch, et al.
Heart (British Cardiac Society)|March 5, 1999
Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failureE Arbustini, R Fasani, P Morbini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 15, 2018
Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimodL Ferre', F Clarelli, G Sferruzza, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 3, 2007
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term resultsA Ghezzi, M P Amato, M Capobianco, et al.
Diabetes, Obesity & Metabolism|May 5, 2012
Effect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trialL D Monti, E Setola, P C G Lucotti, et al.
Human Gene Therapy|June 2, 2001
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitisP L Poliani, H Brok, R Furlan, et al.
European Journal of Neurology|March 3, 2011
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosisA Novotna, J Mares, S Ratcliffe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2005
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS studyM S Freedman, G S Francis, E A C M Sanders, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2008
A pilot trial of low-dose naltrexone in primary progressive multiple sclerosisM Gironi, F Martinelli-Boneschi, P Sacerdote, et al.
Brain Stimulation|December 5, 2013
Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot studyF Spagnolo, M A Volonté, M Fichera, et al.
Pageof 59